Lovastatin Inhibits VEGFR and AKT Activation: Synergistic Cytotoxicity in Combination with VEGFR Inhibitors

BACKGROUND: In a recent study, we demonstrated the ability of lovastatin, a potent inhibitor of mevalonate synthesis, to inhibit the function of the epidermal growth factor receptor (EGFR). Lovastatin attenuated ligand-induced receptor activation and downstream signaling through the PI3K/AKT pathway...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Tong T., Trinh, Diane, Addison, Christina L., Dimitroulakos, Jim
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2933231/
https://www.ncbi.nlm.nih.gov/pubmed/20838437
http://dx.doi.org/10.1371/journal.pone.0012563

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2933231/
https://www.ncbi.nlm.nih.gov/pubmed/20838437
http://dx.doi.org/10.1371/journal.pone.0012563

Ejemplares similares